Identificação
            Identificação pessoal
- Nome completo
 - Milene Gonçalves
 
Nomes de citação
- Gonçalves, Milene
 
Identificadores de autor
- Ciência ID
 - 5D14-5239-34EB
 - ORCID iD
 - 0000-0002-4893-1184
 
Telefones
- Telemóvel
 - 
                           
- (351) 919517423 (Pessoal)
 
 
Domínios de atuação
- Ciências Médicas e da Saúde
 
Idiomas
| Idioma | Conversação | Leitura | Escrita | Compreensão | Peer-review | 
|---|---|---|---|---|---|
| Inglês | Utilizador independente (B1) | Utilizador independente (B1) | Utilizador independente (B1) | Utilizador independente (B1) | |
| Português | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) | 
Formação
            | Grau | Classificação | |
|---|---|---|
| 
                                  2022/09/10 - 2028 
                                 Em curso 
                               | 
                              Integrated Master’s degree in medicine (Licenciatura)
                                  Universidade de Coimbra - Faculdade de Medicina, Portugal 
                               | 
                              |
| 
                                  2020/09/01 - 2024/05/13 
                                 Concluído 
                               | 
                               Dottorato di ricerca in Medicina Clinica e Sperimentale e Medical Humanities - co-tutela (Dottorato di Ricerca)
                                  Università degli Studi dell'Insubria, Itália 
                                 "IMMU-KYN-PARK: exploring indoleamine 2,3-dioxygenase 1 in peripheral immune system in Parkinson's disease (double PhD agreement)" (TESE/DISSERTAÇÃO) 
                               | 
                              |
| 
                                  2018/10/01 - 2024/05/13 
                                 Concluído 
                               | 
                              PhD Programme in Experimental Biology and Biomedicine (Doutoramento)
                                  Especialização em Specialization in Neuroscience and Disease 
                                 Universidade de Coimbra, Portugal 
                                 "IMMU-KYN-PARK: exploring indoleamine 2,3-dioxygenase 1 in peripheral immune system in Parkinson's disease" (TESE/DISSERTAÇÃO) 
                               | 
                              |
| 
                                  2019/09/09 - 2019/09/20 
                                 Concluído 
                               | 
                              Advanced Course on dementia Prevention, 9th – 20th September 2019 (Outros)
                                  Imperial College London School of Public Health, Reino Unido 
                               | 
                              |
| 
                                  2019/01/01 - 2019/01/31 
                                 Concluído 
                               | 
                              Animal Research and Welfare Certification  (Curso de Especialização Tecnológica)
                                  Direcção-Geral de Alimentação e Veterinária, Portugal 
                               | 
                              |
| 
                                  2012 
                                 Concluído 
                               | 
                              Master in Biochemistry  (Mestrado)
                                  Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal 
                                 "Caracterização da Resposta Imune Periférica na Doença de Alzheimer" (TESE/DISSERTAÇÃO) 
                               | 
                              18 | 
| 
                                  2010 - 2011 
                                 Concluído 
                               | 
                              English for academics (Outros)
                                  Universidade de Coimbra Faculdade de Letras, Portugal 
                               | 
                              15 | 
| 
                                  2010 
                                 Concluído 
                               | 
                              Biomedical Sciences (Licenciatura)
                                  Instituto Politécnico de Coimbra Escola Superior de Tecnologia da Saúde de Coimbra, Portugal 
                                 "Prevalência da Panton Valentine-Leukocidin em Staphylococcus aureus associados a Infecções do Tracto Respiratório" (TESE/DISSERTAÇÃO) 
                               | 
                              17 | 
Percurso profissional
            Outros
| Categoria Profissional Instituição de acolhimento  | 
                              Empregador | |
|---|---|---|
| 2023/05/01 - Atual | Biomedical Scientist | Serviço de Sangue e Medicina Transfusional, Centro Hospitalar e Universitário de Coimbra, Portugal | 
| 2018/10/01 - 2023/04/30 | PhD Student fellow: 'Kynurenine pathway as a Potential Therapeutic Target in Parkinson's Disease', reference SFRH/BD/139013/2018 | Fundação para a Ciência e a Tecnologia, Portugal | 
| CNC.IBILI, Portugal | ||
| 2013/05/01 - 2018/07/16 | Biomedical scientist & Quality Manager | Laboratório de São José, Lda, Portugal | 
| 2012/01/01 - 2012/12/31 | Researcher fellow at the project "LRRK2 role on auto-antibody production by human B cells" funded by Michael J. Fox Foundation | Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal | 
| 2010/07/15 - 2011/09/30 | Voluntary researcher at the Immunology group of Center of Neuroscience and cell Disease grupo de Imunologia | Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal | 
| 2010/01/15 - 2010/05/29 | Voluntary Researcher Voluntary researcher - “Allergic Inflammation” project of the Pneumonology Center of Coimbra University | Centro Hospitalar e Universitário de Coimbra EPE, Portugal | 
| 2009/10/26 - 2009/11/20 | Biochemistry internship - Biomedical Sciences | Hospitais da Universidade de Coimbra, Portugal | 
| 2009/09/15 - 2009/10/22 | Immunology and Virology internship - Biomedical Sciences | Instituto Português do Sangue e da Transplantação IP, Portugal | 
| 2009/06/01 - 2009/07/01 | Haematology internship - Biomedical Sciences | Centro Hospitalar e Universitário de Coimbra EPE, Portugal | 
| 2009/04/14 - 2009/05/14 | Haematology internship - ERASMUS mobility - Biomedical Sciences | Turku University Hospital (TYKS OS 131; TKYS 933), Finlândia | 
| 2009/02/24 - 2009/04/03 | Microbiology internship - ERASMUS mobility - Biomedical Sciences | National Institute for Health and Welfare, Finlândia | 
Projetos
            Bolsa
| Designação | Financiadores | |
|---|---|---|
| 2018/10/01 - 2023/04/30 | Kynurenine pathway as a Potential Therapeutic Target in Parkinson's Disease', reference SFRH/BD/139013/2018
                                  SFRH/BD/139013/2018 
                                 Bolseiro de Doutoramento
                                     
                              CNC.IBILI, Portugal 
                                  | 
                              
                                  Concluído 
                               | 
                           
Produções
            Publicações
| Artigo em revista | 
                                 
  | 
                           
Atividades
            Apresentação oral de trabalho
| Título da apresentação | Nome do evento Anfitrião (Local do evento)  | 
                           |
|---|---|---|
| 2023 | Oral presentation: Dopamine reduces indoleamine 2,3- dyoxigenase-1 inducibility in circulating myeloid cells through b-adrenergic receptors: is this relevantin Parkinson’s Disease? | 53rd Meeting of the Portuguese Society of Pharmacology, 41st Meeting of Clinical Pharmacology and  22nd Meeting of Toxicology
                                  Portuguese Society of Pharmacology 
                               | 
                           
| 2023 | Oral presentation (PhD supervisor): SOS Salbutamol: are ß2 Adrenergic receptors druggable targets to modulate inflammation in Parkinson¿s Disease? | 1st Immune Parknet Annual Conference
                                   (Turquia) 
                               | 
                           
| 2023 | Oral presentation: Dopamine as an immunomodulator agent in Parkinson’s disease. | Annual congress of Portuguese Society of movement disorders 2023.
                                  Portuguese Society of Movement Diseases  (Portugal) 
                               | 
                           
| 2023 | Oral presentation (PhD Supervisor): Evaluating the expression and activity of IDO1 in human circulating cells under a specific proinflammatory milieu: is this a possible in vitro Parkinson´s Disease model? | 2nd Immune Parknet Annual Conference
                                   (Espanha) 
                               | 
                           
| 2023 | Poster presentation (PhD supervisor): SOS Salbutamol: are ß2 receptors druggable targets to modulate inflammation in Parkinson’s Disease | 19th World Congress of Basic and Clinical Pharmacology,
                                   British Pharmacological Society and International Union of Basic and Clinical Pharmacologists (IUPHAR) (Scotland - Glasgow) 
                               | 
                           
| 2022 | Poster presentation: DO1 - a druggable target in immune dysregulation in Parkinson¿s Disease. | CIBB – Center for Innovative Biomedicine and Biotechnology meeting 2022 | 
| 2022 | Oral presentation as a guest speaking : Are IDO1+myeloid cells a druggable target in Parkinson¿s Disease. | brain corner session of moving on series – what contributes to the well-being in PD?
                                  portuguese society of neurology, Portuguese Society of Movement Diseases and BIAL. 
                               | 
                           
| 2022 | Virtual poster presentation: Are IDO1+Dendritic cells a druggable target in Parkinson’s Disease? | Neuroscience meeting from Society for neuroscience 2022 | 
| 2021 | Oral Presentation: Exploring IDO1 in PD: Immune cellular distribution and Interaction | Octave scientific journey of the PhD programme in Clinical and Experimental Medicine and Medical Humanities
                                  University of Insubria (Insubria, Itália) 
                               | 
                           
| 2020 | Oral presentation: IDO1 activation decreases T cell proliferation | Seventh scientific journey of the PhD programme in Clinical and Experimental Medicine and Medical Humanities of University
                                 of Insubria
                                  University of Insubria (Insubria, Itália) 
                               | 
                           
| 2012/07/13 | Alterations in peripheral B Lymphocytes subsets of Mild cognitive Impairment and early stage Alzheimer’s disease patients (Poster). | Alzheimer’s Association International Conference, Vancouver 2012
                                   (Vancouver, Canadá) 
                               | 
                           
Distinções
            Outra distinção
| 2018 | PhD Schoolarship - SFRH/BD/139013/2018 - Kynurenine pathway as a Potential Therapeutic Target in Parkinson's Disease
                                  Fundação para a Ciência e a Tecnologia, Portugal 
                               | 
                           
| 2010 | Merit Schoolarship  2008/2009 (Despacho nº 13531/2009 16 de Maio MCTES)
                                  Instituto Politécnico de Coimbra, Portugal 
                               | 
                           
